*Some Market data delayed by 15 mins.

CytomX Therapeutics, Inc.

Symbol: CTMX (NASDAQ)
2.06 ▼ (-0.72%) -0.015

Company Description:
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Key Stats
  • Today's Open: $2.09
  • Today's High: $2.16
  • Today's Low: $2.055
  • Today's Volume: 639.04K
  • Yesterday Close: $2.07
  • Yesterday High: $2.135
  • Yesterday Low: $2.06
  • Yesterday Volume: 1.57M
  • Last Min Volume: 400
  • Last Min High: $2.055
  • Last Min Low: $2.055
  • Last Min VWAP: $2.055
Company Profile
  • Name: CytomX Therapeutics, Inc.
  • Website: https://www.cytomx.com
  • Listed Date: 2015-10-08
  • Location: SOUTH SAN FRANCISCO, CA
  • Market Status: Active
  • CIK Number: 0001501989
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $341.37M
  • Round Lot: 100
  • Outstanding Shares: 164.91M
  • Asset Type: CS
RECENT FILINGS FOR CTMX
Filing Date Filing Type Format
2025-08-21 SCHEDULE 13G View
2025-08-18 EFFECT View
2025-08-14 SCHEDULE 13G View
2025-08-14 SCHEDULE 13G/A View
2025-08-14 SCHEDULE 13G/A View
2025-08-13 8-K View
2025-08-07 S-8 View
2025-08-07 S-3 View
2025-08-07 8-K View
2025-08-07 10-Q View
2025-08-06 SCHEDULE 13G View
2025-07-29 SCHEDULE 13G/A View
2025-07-09 SCHEDULE 13G/A View
2025-07-09 SCHEDULE 13G/A View
2025-06-17 4 View
2025-06-17 4 View
2025-06-17 4 View
2025-06-13 4 View
2025-06-13 4 View
2025-06-13 4 View
Latest News on CTMX

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.